Methemoglobinemia and dapsone levels in patients with leprosy

被引:10
作者
Fernandes Vieira, Jose Luiz [1 ]
Bardarez Riveira, Juan Gonzalo [1 ]
Silva Martins, Ana de Nazare [1 ]
da Silva, Jorge Pereira [1 ]
Salgado, Claudio Guedes [1 ]
机构
[1] Fed Univ Para, Toxicol Lab, Sch Pharm, Belem, PA, Brazil
关键词
methahemoglobinemia; dapsone; leprosy; HYDROXYLAMINE METABOLITES; TOXICITY; BLOOD;
D O I
10.1590/S1413-86702010000300022
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The objective of this work was to determine the methemoglobinemia and correlate with dapsone levels in multibacillary leprosy patients under leprosy multi-drug therapy. Thirty patients with laboratory and clinical diagnosis of multibacillary leprosy were enrolled. Dapsone was analyzed by high performance liquid chromatography and methemoglobinemia by spectrophotometry. The mean dapsone concentrations in male was 1.42 g/mL and in female was 2.42 g/mL. The mean methemoglobin levels in male was 3.09 mu g/mL; 191%, and in female was 2.84 +/- 1.67%. No correlations were seen between dapsone levels and methemoglobin in male and female patients. Our results demonstrated that the dosage of dapsone in leprosy treatment does not promote a significant methemoglobinemia.
引用
收藏
页码:319 / 321
页数:3
相关论文
共 10 条
[1]  
AB G, 1994, ANTIMICROB AGENTS CH, V38, P2227
[2]   Dapsone toxicity: Some current perspectives [J].
Coleman, MD .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1995, 26 (07) :1461-1467
[3]  
Halim N K D, 2002, East Afr Med J, V79, P100
[4]   SENSITIVE MICROMETHOD FOR DETERMINATION OF METHEMOGLOBIN IN BLOOD [J].
HEGESH, E ;
GRUENER, N ;
COHEN, S ;
BOCHKOVSKY, R ;
SHUVAL, HI .
CLINICA CHIMICA ACTA, 1970, 30 (03) :679-+
[5]  
Kaur I, 2001, INT J LEPROSY, V69, P247
[6]   High-performance liquid chromatographic method with ultraviolet detection for the determination of dapsone and its hydroxylated metabolite in human plasma [J].
Kwadijk, S ;
Toraño, JS .
BIOMEDICAL CHROMATOGRAPHY, 2002, 16 (03) :203-208
[7]  
Reilly TP, 1999, J PHARMACOL EXP THER, V288, P951
[8]   DAPSONE-INDUCED HEMATOLOGIC TOXICITY - COMPARISON OF THE METHEMOGLOBIN-FORMING ABILITY OF HYDROXYLAMINE METABOLITES OF DAPSONE IN RAT AND HUMAN BLOOD [J].
VAGE, C ;
SAAB, N ;
WOSTER, PM ;
SVENSSON, CK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 129 (02) :309-316
[9]   Dapsone and sulfones in dermatology: Overview and update [J].
Zhu, YI ;
Stiller, MJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (03) :420-434
[10]   CLINICAL PHARMACOKINETICS OF DAPSONE [J].
ZUIDEMA, J ;
HILBERSMODDERMAN, ESM ;
MERKUS, FWHM .
CLINICAL PHARMACOKINETICS, 1986, 11 (04) :299-315